Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001193125-26-023094

Chief Operating Officer acquired 190,376 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sattarzadeh Sherwin · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-05 Grant or award : show line 1 in the form +190,376 190,376 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-05 Grant or award : show line 2 in the form Stock Option (right to buy) +444,209 444,209 D
Loading xslF345X05/ownership.xml…